The resolution reflects the findings and recommendations of the Society for Endocrinology.
The resolution reflects the findings and recommendations of the Society for Endocrinology, the peer-reviewed scientific explanation of endocrine-disrupting chemicals published by the Company last June. The Scientific Statement presents evidence that endocrine disruptors substances that interfere with hormone biosynthesis, metabolism or action of the health effects, in adverse developmental, reproductive, neurological and immune effects in humans and wildlife.
The Endocrine Society hopes that additional state medical boards will follow the courageous leadership of the California Medical Association. The company supports the passage of all efforts to increase scientific understanding of the effects of endocrine disruptors and in state and federal policies level, the be protected. Be protected.Pneumococcal diseasePneumococcal disease concerns of both children and adults alike on of worldwide worldwide pneumococci the bacterium Streptococcus pneumoniae the bacterium Streptococcus pneumoniae and describes a group of illnesses, including invasive infections such bacteraemia /. Sepsis and meningitis, and pneumonia and infections of the upper airways, including otitis media and sinusitis.
In particular, since the imposition to Prevenar and referred to as the PCV7 to Paediatric vaccination in Germany, as scheduled in 2006 there was a 50 per cent reduce vaccines – type to invasive pneumococcal disease in children younger than 2 years in comparison by an pre – vaccine program. In addition, a slight reduction from of the A vaccine type of among children aged 2-5 years IPD a unvaccinated group, has also been documented which . For children ‘These data are convincing and indicate to rapid reduction in the IPD among German children on the inclusion of Prevenar in the domestic childhood in Germany vaccination schedule,’Dr. Mark van der Linden, Head of the National Reference Center for Streptococci of Medical Microbiology Medical Microbiology, RWTH-Aachen, Germany. ‘It is important that the results documented in in accordance with to the reduce risk through France and the UK, which child is routine immunization with Prevenar, to effects the vaccine in countries in all of Europe in Europe .